LEAH BAYLISS: Open Payments
NPI 1396922779 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 16 payments from 8 companies in 2025. Trend: 2023 $360 · 2024 $363 · 2025 $516
Food & beverage: $407Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $192 |
| PFIZER INC. | 1 | $103 |
| Janssen Biotech, Inc. | 1 | $100 |
| UCB, Inc. | 1 | $43 |
| GENZYME CORPORATION | 1 | $26 |
| Boston Scientific Corporation | 1 | $21 |
| LNHC, Inc | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: RINVOQ, LITFULO, TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, General - DBS, ZELSUVMI.
Industry payments across TX — which companies pay providers there.
